Security Snapshot

HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) Institutional Ownership

CUSIP: 42225K106

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2020

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • HIIQ - HEALTH INS INNOVATIONS INC - COM CL A is tracked under CUSIP 42225K106.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 107 to 0 between Q4 2019 and Q1 2020.
  • SEC-reported value moved from $267,322,240 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

42225K106

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
25
Latest
n/a
Rows shown
1-25 of 25
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2020 Q1 0 $0 -$241,585,082 0
2019 Q4 13,857,599 $267,322,240 -$16,723,366 $19.29 107
2019 Q3 12,097,651 $301,551,395 -$50,110,305 $24.93 116
2019 Q2 13,976,067 $361,996,367 -$74,979,082 $25.92 123
2019 Q1 16,773,951 $449,881,640 -$3,287,316 $26.82 139
2018 Q4 16,939,006 $452,769,754 +$19,254,655 $26.73 140
2018 Q3 13,416,267 $825,620,482 -$32,444,221 $61.65 144
2018 Q2 14,584,461 $471,767,432 +$62,096,998 $32.35 138
2018 Q1 12,776,914 $369,282,774 -$5,550,589 $28.90 127
2017 Q4 13,109,369 $327,064,471 +$45,828,225 $24.95 102
2017 Q3 11,196,809 $162,291,634 -$6,929,480 $14.50 113
2017 Q2 10,575,604 $248,567,566 +$77,448,070 $23.50 99
2017 Q1 8,179,277 $130,866,000 +$69,626,562 $16.00 76
2016 Q4 3,973,594 $70,925,000 +$22,941,613 $17.85 44
2016 Q3 3,512,783 $18,439,000 -$2,095,559 $5.25 31
2016 Q2 4,103,120 $16,125,000 -$1,784,297 $3.93 31
2016 Q1 4,248,209 $25,949,000 -$1,931,163 $6.11 21
2015 Q4 4,555,186 $30,518,000 +$1,561,333 $6.70 23
2015 Q3 4,332,402 $21,662,000 -$1,028,133 $5.00 24
2015 Q2 4,580,861 $22,767,000 -$2,164,906 $4.97 28
2015 Q1 4,620,708 $35,956,250 -$1,571,777 $7.81 30
2014 Q4 4,857,422 $34,755,146 -$1,511,089 $7.16 35
2014 Q3 4,758,569 $51,519,881 -$4,084,563 $10.79 40
2014 Q2 5,143,292 $63,367,289 -$927,437 $12.32 35
2014 Q1 5,248,941 $54,203,525 +$8,477,842 $10.34 41
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .